Prostate Cancer News and reporting on prostate cancer. Genomic Differences in Prostate Cancer Found Among African Americans, European Americans The analysis underscores differences in gene expression and biological pathways that could influence treatments and disease outcomes. Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions. Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve Its ProteinSimple proteomic analytical tools and Advanced Cell Diagnostics tissue biopsy products were standouts in the quarter, Bio-Techne's CEO said. Prostate Cancer Study Shows Oncotype DX GPS Test Accurately Measures Long-Term Outcomes Premium The 20-year study showed the test provided an accurate assessment of the risk of long-term metastases and mortality for patients with localized prostate cancer. Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Researchers used the company's large clinical-genomic database to characterize HRD reversion mutations and explore their potential function in patient resistance to PARP inhibitors. Mar 23, 2021 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test Mar 17, 2021 Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Mar 10, 2021 Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test Mar 3, 2021 MDxHealth 2020 Revenues Up 57 Percent Mar 2, 2021 Oppenheimer Initiates Coverage of MDxHealth at Outperform Mar 1, 2021 Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Feb 3, 2021 Veracyte to Acquire Decipher Biosciences for $600M; Prelim Q4 Revenues Grow 14 to 18 Percent Feb 2, 2021 Bio-Techne Fiscal Q2 Revenues Rise 21 Percent Jan 4, 2021 Genetic Score Predicts Prostate Cancer Risk Across Ancestry Populations Nov 25, 2020 European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer Premium Nov 23, 2020 Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs Premium Nov 19, 2020 Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research Nov 9, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza Nov 6, 2020 Large-Scale Cancer Proteomics Study Provides Insights on Drug Resistance, Effective Therapy Combos Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 21, 2020 MDxHealth Q3 2020 Revenues Drop 6 Percent Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 10, 2020 Epic Sciences, MSK Identify Potential Prostate Cancer Therapy Response Biomarker Premium Sep 9, 2020 NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.